News
This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
The FDA’s decision to clear the Apple Watch is a big deal because it shows they are open to new kinds of medical devices. It ...
Researchers at the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have found that ...
Previously, due to the risk of cytokine release syndrome and neurological toxicities, many CAR T-cell therapies included a REMS requirement.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine ...
Certain words in your Amazon listings can trigger compliance warnings. Understand how to stay accurate while avoiding policy violations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results